DOSE ESCALATION AND DOSE EXPANSION PHASE I STUDY TO ASSESS THE SAFETY AND CLINICAL ACTIVITY OF MULTIPLE DOSES OF NKR-2 ADMINISTERED CONCURRENTLY WITH FOLFOX IN COLORECTAL CANCER WITH POTENTIALLY RESECTABLE LIVER METASTASES: